Grace Xiuqing Li, MD
Internal Medicine · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
- Since medical school
- 26 years
- Graduated 2000
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Hospitals listed: 051589. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Li’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A144150 · Current
Licensed to practise in California · since 2016 · expires 2028-02-29 · Shanghai Second Medical University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Hematology
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Medical Oncology
Medicaid work
$0 in 2018
Medicaid paid $0 for 66 billed services this clinician did in 2018, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 34 | $0 |
| COMPREHENSIVE METABOLIC PANEL | 32 | $0 |
| 2018 | 66 | 2 | 15 | $0 |
Drugs they prescribed that Part D paid
$2,863,504
Pharmacies billed $2,863,504 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 5% of their Part D prescriptions (45 of 954) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
769 generic and fewer than 11 brand-name prescriptions · $2,863,504 in drug cost · 15 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cabometyx | 33 | $649,395 | $19,679 |
| Ibrance | 33 | $507,873 | $15,390 |
| Lenvima | 24 | $495,131 | $20,630 |
| Xtandi | 25 | $304,956 | $12,198 |
| Lynparza | 17 | $233,891 | $13,758 |
See all 19 drugs
| Cabometyx | 33 | $649,395 | $19,679 |
| Ibrance | 33 | $507,873 | $15,390 |
| Lenvima | 24 | $495,131 | $20,630 |
| Xtandi | 25 | $304,956 | $12,198 |
| Lynparza | 17 | $233,891 | $13,758 |
| Kisqali | 11 | $153,982 | $13,998 |
| Abiraterone Acetate | 76 | $9,835 | $129 |
| Anastrozole | 269 | $7,497 | $28 |
| Levothyroxine | 47 | $732 | $16 |
| Hydroxyurea | 17 | $717 | $42 |
| Letrozole | 35 | $686 | $20 |
| Tamoxifen Citrate | 26 | $655 | $25 |
| Hydrocodone-Acetaminophen | 16 | $564 | $35 |
| Potassium Chloride | 12 | $386 | $32 |
| Prednisone | 48 | $383 | $8 |
| Bicalutamide | 11 | $381 | $35 |
| Oxycodone | 28 | $379 | $14 |
| Gabapentin | 25 | $324 | $13 |
| Alendronate | 22 | $190 | $9 |
Year by year
| 2024 | 954 | 205 | 5% (45) | None | $2,863,504 |
| 2023 | 771 | 166 | 3% (25) | 21% | $2,431,688 |
| 2022 | 675 | 140 | 4% (27) | None | $964,385 |
| 2021 | 349 | 72 | 9% (30) | None | $619,123 |
| 2020 | 96 | 38 | 13% (12) | 15% | $42,804 |
| 2019 | 198 | 64 | 13% (26) | 21% | $305,996 |
| 2018 | 194 | 59 | 8% (16) | 22% | $262,703 |
| 2017 | 76 | 26 | None | None | $26,914 |
| 2016 | 100 | 43 | None | None | $3,041 |
| 2015 | 40 | 18 | None | None | $1,152 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Cabometyx | 26 | $550,834 | $21,186 |
| Lenvima | 19 | $466,051 | $24,529 |
| Ibrance | 25 | $400,381 | $16,015 |
| Xtandi | 27 | $371,397 | $13,755 |
| Zejula | 25 | $248,701 | $9,948 |
| Lynparza | 13 | $210,327 | $16,179 |
| Abiraterone Acetate | 70 | $9,268 | $132 |
| Anastrozole | 229 | $5,999 | $26 |
| Hydroxyurea | 21 | $878 | $42 |
| Tamoxifen Citrate | 24 | $804 | $33 |
| Potassium Chloride | 16 | $726 | $45 |
| Gabapentin | 35 | $606 | $17 |
| Levothyroxine | 27 | $534 | $20 |
| Letrozole | 30 | $505 | $17 |
| Prednisone | 37 | $272 | $7 |
| Oxycodone | 18 | $211 | $12 |
| Bicalutamide | 13 | $208 | $16 |
| Alendronate | 13 | $112 | $9 |
2022: 20 drugs
| Lenvima | 19 | $360,819 | $18,990 |
| Zejula | 32 | $237,873 | $7,434 |
| Abiraterone Acetate | 55 | $8,138 | $148 |
| Anastrozole | 162 | $3,965 | $24 |
| Tamoxifen Citrate | 21 | $997 | $47 |
| Potassium Chloride | 21 | $904 | $43 |
| Dexamethasone | 15 | $615 | $41 |
| Hydroxyurea | 14 | $587 | $42 |
| Gabapentin | 27 | $481 | $18 |
| Levothyroxine | 19 | $451 | $24 |
| Prednisone | 40 | $356 | $9 |
| Letrozole | 22 | $318 | $14 |
| Prochlorperazine Maleate | 12 | $243 | $20 |
| Ondansetron | 22 | $223 | $10 |
| Oxycodone | 18 | $179 | $10 |
| Hydrocortisone | 12 | $169 | $14 |
| Olanzapine | 12 | $139 | $12 |
| Nystatin | 12 | $136 | $11 |
| Famotidine | 13 | $118 | $9 |
| Hydroxyzine | 12 | $91 | $8 |
2021: 8 drugs
| Zejula | 31 | $293,447 | $9,466 |
| Abiraterone Acetate | 18 | $3,172 | $176 |
| Anastrozole | 69 | $1,722 | $25 |
| Gabapentin | 19 | $337 | $18 |
| Prednisone | 21 | $303 | $14 |
| Oxycodone | 21 | $244 | $12 |
| Ondansetron | 20 | $196 | $10 |
| Famotidine | 18 | $146 | $8 |
2019: 1 drug
| Hydrocodone-Acetaminophen | 15 | $243 | $16 |
2018: 2 drugs
| Ondansetron | 14 | $209 | $15 |
| Acyclovir | 16 | $206 | $13 |
Money from drug and device companies
$430 in 2022
| 2022 | 1 | 1 | $430 | $430 |
| 2020 | 9 | 16 | None | $738 |
| 2019 | 11 | 24 | None | $1,232 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Blenrep | $430 | 1 payment
|
See the published payment
| GlaxoSmithKline | Consulting · 2022-05-26 | Blenrep | $430 |
See earlier years (2020, 2019)
2020: $738
| Celgene | Inrebic | $239 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $155 | 2 payments
|
| Amgen | Kyprolis | $136 | 3 payments
|
| Pfizer | Vyndaqel | $121 | 1 payment
|
| Alexion Pharmaceuticals | Ultomiris | $20 | 1 payment
|
| Incyte | Jakafi | $20 | 1 payment
|
| Jazz Pharmaceuticals | Vyxeos | $18 | 1 payment
|
| Puma Biotechnology | Nerlynx | $15 | 1 payment
|
| Novartis Pharmaceuticals | Promacta | $12 | 1 payment
|
2019: $1,232
| Amgen | Mvasi | $224 | 6 payments
|
| Genentech USA | Tecentriq | $173 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $148 | 2 payments
|
| Merck Sharp & Dohme | Keytruda | $147 | 3 payments
|
| Puma Biotechnology | Nerlynx | $144 | 2 payments
|
| Celgene | Abraxane | $140 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $121 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Nexavar | $42 | 3 payments
|
| Eisai | Lenvima | $37 | 2 payments
|
| Exelixis | Cabometyx | $30 | 1 payment
|
| Dendreon Pharmaceuticals | Provenge | $26 | 1 payment
|
Professional record
- NPI
- 1982017695
- Licence
- CA A144150California A144150: Current · expires 2028-02-29
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 1441 Eastlake Ave Ste 3444, Los Angeles, CA, 90089
- NPI first listed
- 2014-06-10
- NPI last updated
- 2022-01-10
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 222 S Woods Mill Rd, Chesterfield, MO, 63017
This office lists an electronic records connection.